A detailed history of Pure Financial Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pure Financial Advisors, LLC holds 21,071 shares of MRK stock, worth $2.07 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
21,071
Previous 26,310 19.91%
Holding current value
$2.07 Million
Previous $3.26 Million 26.56%
% of portfolio
0.06%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$111.15 - $128.97 $582,314 - $675,673
-5,239 Reduced 19.91%
21,071 $2.39 Million
Q2 2024

Jul 18, 2024

SELL
$123.8 - $132.96 $6,190 - $6,648
-50 Reduced 0.19%
26,310 $3.26 Million
Q1 2024

Apr 16, 2024

BUY
$113.24 - $131.95 $51,977 - $60,565
459 Added 1.77%
26,360 $3.48 Million
Q4 2023

Jan 08, 2024

BUY
$100.18 - $109.02 $256,060 - $278,655
2,556 Added 10.95%
25,901 $2.82 Million
Q3 2023

Oct 10, 2023

BUY
$102.95 - $114.33 $145,674 - $161,776
1,415 Added 6.45%
23,345 $2.4 Million
Q2 2023

Jul 10, 2023

SELL
$108.61 - $118.38 $6,299 - $6,866
-58 Reduced 0.26%
21,930 $2.53 Million
Q1 2023

Apr 11, 2023

BUY
$102.94 - $114.86 $58,264 - $65,010
566 Added 2.64%
21,988 $2.34 Million
Q4 2022

Jan 09, 2023

BUY
$87.44 - $112.11 $3,759 - $4,820
43 Added 0.2%
21,422 $0
Q3 2022

Oct 06, 2022

BUY
$84.53 - $94.96 $7,185 - $8,071
85 Added 0.4%
21,379 $1.84 Million
Q2 2022

Jul 08, 2022

BUY
$83.49 - $94.64 $56,188 - $63,692
673 Added 3.26%
21,294 $1.94 Million
Q1 2022

Apr 12, 2022

BUY
$73.51 - $82.4 $6,027 - $6,756
82 Added 0.4%
20,621 $1.69 Million
Q4 2021

Jan 12, 2022

BUY
$72.28 - $90.54 $50,885 - $63,740
704 Added 3.55%
20,539 $1.57 Million
Q3 2021

Oct 07, 2021

BUY
$71.68 - $78.83 $3,153 - $3,468
44 Added 0.22%
19,835 $1.49 Million
Q1 2021

Apr 09, 2021

BUY
$68.86 - $81.11 $10,122 - $11,923
147 Added 0.75%
19,791 $1.53 Million
Q4 2020

Jan 12, 2021

BUY
$71.77 - $79.65 $8,110 - $9,000
113 Added 0.58%
19,644 $1.61 Million
Q3 2020

Oct 07, 2020

BUY
$73.18 - $82.95 $3,732 - $4,230
51 Added 0.26%
19,531 $1.62 Million
Q2 2020

Jul 08, 2020

BUY
$70.42 - $80.13 $9,577 - $10,897
136 Added 0.7%
19,480 $1.51 Million
Q1 2020

Apr 07, 2020

SELL
$63.36 - $87.82 $33,137 - $45,929
-523 Reduced 2.63%
19,344 $1.49 Million
Q4 2019

Jan 09, 2020

BUY
$77.58 - $87.54 $23,739 - $26,787
306 Added 1.56%
19,867 $1.81 Million
Q3 2019

Oct 09, 2019

BUY
$76.08 - $82.93 $2,891 - $3,151
38 Added 0.19%
19,561 $1.65 Million
Q2 2019

Jul 11, 2019

BUY
$69.84 - $81.59 $26,190 - $30,596
375 Added 1.96%
19,523 $1.64 Million
Q1 2019

Apr 05, 2019

SELL
$69.58 - $79.36 $2,783 - $3,174
-40 Reduced 0.21%
19,148 $1.59 Million
Q4 2018

Jan 11, 2019

SELL
$65.24 - $75.71 $68,958 - $80,025
-1,057 Reduced 5.22%
19,188 $1.47 Million
Q3 2018

Oct 04, 2018

BUY
$57.69 - $67.84 $12,980 - $15,264
225 Added 1.12%
20,245 $1.44 Million
Q2 2018

Jul 10, 2018

BUY
$50.83 - $59.72 $19,671 - $23,111
387 Added 1.97%
20,020 $1.22 Million
Q1 2018

Apr 05, 2018

BUY
$50.96 - $59.23 $2,395 - $2,783
47 Added 0.24%
19,633 $1.07 Million
Q4 2017

Jan 10, 2018

BUY
$51.62 - $61.64 $2,116 - $2,527
41 Added 0.21%
19,586 $1.1 Million
Q3 2017

Oct 11, 2017

BUY
$58.67 - $63.13 $1.15 Million - $1.23 Million
19,545
19,545 $1.25 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pure Financial Advisors, LLC Portfolio

Follow Pure Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pure Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pure Financial Advisors, LLC with notifications on news.